Kinetic properties of nitric oxide synthase in cerebral cortex and cerebellum of morphine tolerant mice

Pharmacology

Volumn 56, Issue 5, 1998, Pages 252-256

  Bhargava, Hemendra N ^a   Kumar, Shailendra ^a   Barjavel, Marc J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cerebellum; Cortex; Kinetics; Morphine; Nitric oxide synthase

Indexed keywords

ARGININE; BRAIN ENZYME; CITRULLINE; MORPHINE; NITRIC OXIDE SYNTHASE; TRITIUM;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME KINETICS; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; CEREBELLUM; CEREBRAL CORTEX; DRUG TOLERANCE; KINETICS; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; NITRIC OXIDE SYNTHASE;

EID: 0031919506     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028205     Document Type: Article

References (18)

1. Bhargava HN: Diversity of agents which modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior. Pharmacol Rev 1994;46: 293-324.
2. Johnson SM, Fleming WW: Mechanisms of cellular adaptive sensitivity changes: Application to tolerance and dependence. Pharmacol Rev 1989;41:435-488.
3. Bredt DS, Snyder SH: Nitric oxide, a novel neuronal messenger. Neuron 1992;8:3-11.
4. MoncadaS, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
5. Bhargava HN: Attenuation of tolerance to and physical dependence on morphine in the rat by inhibition of nitric oxide synthase. Gen Pharmacol 1995;26:1049-1053.
6. 5 enkephalin and morphine in mice. Neuropeptides 1996;30:219-223.
7. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW: Blockade of tolerance to morphine but not to κ-opioids by nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 1993;90:5162-5166.
8. 4]deltorphin II in mice. Peptides 1996;17:619-623.
9. Cappendijk SLT, DeVries R, Dzoljic MR: Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett 1993;162:97-100.
10. Kimes AS, Vaupel DB, London ED: Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 1993;112:521-524.
11. G-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res 1994;642: 153-159.
12. Bhargava HN, Thorat SN: Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology 1996;52:86-91.
13. Barjavel MJ, Bhargava HN: Effect of morphine tolerance and abstinence on nitric oxide synthase activity in brain regions and spinal cord of the mouse. Soc Neurosci Abstr 1994;20:1234.
14. Babey AM, Kolesnikov Y, Cheng J, Inturrisi CE, Trifilletti RR, Pasternak GW: Nitric oxide and opioid tolerance. Neuropharmacology 1994;33:1463-1470.
15. Leza JC, Lizasoain I. San-Martin-Clark O, Lorenzo P: Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity. Eur J Pharmacol 1995;285:95-98.
16. Barjavel MJ, Bhargava HN: Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate. Neurosci Lett 1994;181:27-30.
17. Barjavel MJ, Bhargava HN: Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: Kinetic analysis. Pharmacology 1995;50:168-174.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.